Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10014444HBVENSG00000081479.15protein_codingLRP2NoNo4036P98164
TVIS10001909HBVENSG00000081479.15protein_codingLRP2NoNo4036P98164
TVIS10001910HBVENSG00000081479.15protein_codingLRP2NoNo4036P98164
TVIS10023422HBVENSG00000081479.15protein_codingLRP2NoNo4036P98164
TVIS10028751HBVENSG00000081479.15protein_codingLRP2NoNo4036P98164
TVIS10023421HBVENSG00000081479.15protein_codingLRP2NoNo4036P98164
TVIS10028752HBVENSG00000081479.15protein_codingLRP2NoNo4036P98164
TVIS30012764HIVENSG00000081479.15protein_codingLRP2NoNo4036P98164
TVIS20002372HPVENSG00000081479.15protein_codingLRP2NoNo4036P98164
TVIS20033461HPVENSG00000081479.15protein_codingLRP2NoNo4036P98164
TCGA Plot Options
Drug Information
GeneLRP2
DrugBank IDDB00013
Drug NameUrokinase
Target IDBE0000942
UniProt IDP98164
Regulation Typesubstrate
PubMed IDs17139284; 17016423; 8241286; 1280065; 7959795
CitationsOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Kanalas JJ: Effect of the nephritogenic autoantibody of Heymann's nephritis on plasminogen-binding to gp330 and activation by urokinase. Biochim Biophys Acta. 1993 Nov 25;1225(1):101-6.@@Kanalas JJ: Analysis of plasmin binding and urokinase activation of plasminogen bound to the Heymann nephritis autoantigen, gp330. Arch Biochem Biophys. 1992 Dec;299(2):255-60.@@Korenberg JR, Argraves KM, Chen XN, Tran H, Strickland DK, Argraves WS: Chromosomal localization of human genes for the LDL receptor family member glycoprotein 330 (LRP2) and its associated protein RAP (LRPAP1). Genomics. 1994 Jul 1;22(1):88-93.
GroupsApproved; Investigational; Withdrawn
Direct ClassificationPeptides
SMILES
PathwaysUrokinase Action Pathway
PharmGKBPA451836
ChEMBLCHEMBL1201420